Your browser doesn't support javascript.
loading
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma.
Okamoto, Akinao; Fujigaki, Hidetsugu; Iriyama, Chisako; Goto, Naoe; Yamamoto, Hideyuki; Mihara, Keichiro; Inaguma, Yoko; Miura, Yasuo; Furukawa, Katsuya; Yamamoto, Yukiya; Akatsuka, Yoshiki; Kasahara, Senji; Miyao, Kotaro; Tokuda, Masutaka; Sato, Seiko; Mizutani, Yuki; Osawa, Michiko; Hattori, Keiko; Iba, Sachiko; Kajiya, Ryoko; Okamoto, Masataka; Saito, Kuniaki; Tomita, Akihiro.
Afiliação
  • Okamoto A; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Fujigaki H; Department of Advanced Diagnostic System Development, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan.
  • Iriyama C; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Goto N; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Yamamoto H; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Mihara K; International Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan.
  • Inaguma Y; Department of Clinical Medicine, Fujita Health University School of Medicine, Toyoake, Japan.
  • Miura Y; Department of Transfusion Medicine and Cell Therapy, Fujita Health University Hospital, Toyoake, Japan.
  • Furukawa K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yamamoto Y; Department of Biochemical and Sciences, Chubu University, Kasugai, Japan.
  • Akatsuka Y; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.
  • Miyao K; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Tokuda M; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Sato S; Department of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan; and.
  • Mizutani Y; Department of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan; and.
  • Osawa M; Department of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan; and.
  • Hattori K; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Iba S; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Kajiya R; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Okamoto M; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Saito K; Department of Oncology, Fujita Health University Okazaki Medical Center, Okazaki, Japan.
  • Tomita A; Department of Advanced Diagnostic System Development, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan.
Blood Adv ; 6(11): 3230-3233, 2022 06 14.
Article em En | MEDLINE | ID: mdl-35026843
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article